Regulation of the expression of the oncogene EVI1 through the use of alternative mRNA 5′-ends
- 15 August 2005
- Vol. 356, 160-168
- https://doi.org/10.1016/j.gene.2005.04.032
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Nuclear retinoid receptors and the transcription of retinoid-target genesPublished by Elsevier ,2004
- Both AML1 and EVI1 oncogenic components are required for the cooperation of AML1/MDS1/EVI1 with BCR/ABL in the induction of acute myelogenous leukemia in miceOncogene, 2004
- T-cell-derived Interleukin-17 Regulates the Level and Stability of Cyclooxygenase-2 (COX-2) mRNA through Restricted Activation of the p38 Mitogen-activated Protein Kinase CascadeJournal of Biological Chemistry, 2003
- High EVI1 expression predicts poor survival in acute myeloid leukemia: a study of 319 de novo AML patientsBlood, 2002
- Retinoic Acid Attenuates Inducible Nitric Oxide Synthase (NOS2) Activation in Cultured Rat Cardiac Myocytes and Microvascular Endothelial CellsJournal of Molecular and Cellular Cardiology, 2001
- Stabilization of Interleukin-2 mRNA by the c-Jun NH 2 -Terminal Kinase PathwayScience, 1998
- Establishment of a novel human myeloid leukaemia cell line (HNT-34) with t(3;3)(q21;q26), t(9;22)(q34;q11) and the expression of EVI1 gene, P210 and P190 BCR/ABL chimaeric transcripts from a patient with AML after MDS with 3q21q26 syndrome.British Journal of Haematology, 1997
- The Evil proto-oncogene is required at midgestation for neural, heart, and paraxial mesenchyme developmentMechanisms of Development, 1997
- Regulation of Gene Expression of a Binding Protein for Fibroblast Growth Factors by Retinoic AcidJournal of Biological Chemistry, 1996
- Intergenic splicing of MDS1 and EVI1 occurs in normal tissues as well as in myeloid leukemia and produces a new member of the PR domain family.Proceedings of the National Academy of Sciences, 1996